These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3093352)

  • 21. Growth hormone (GH) responses to arginine and L-dopa alone and after GHRH pretreatment.
    Page MD; Dieguez C; Valcavi R; Edwards C; Hall R; Scanlon MF
    Clin Endocrinol (Oxf); 1988 May; 28(5):551-8. PubMed ID: 3145820
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of oral glucose administration on plasma growth hormone-releasing hormone (GHRH)-like immunoreactivity levels in normal subjects and patients with idiopathic GH deficiency: evidence that GHRH is released not only from the hypothalamus but also from extrahypothalamic tissue.
    Kashio Y; Chihara K; Kita T; Okimura Y; Sato M; Kadowaki S; Fujita T
    J Clin Endocrinol Metab; 1987 Jan; 64(1):92-7. PubMed ID: 3097059
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Negative correlation between plasma GHRH values and growth velocity in short prepubertal children.
    Evain-Brion D; Porquet D; Fjellestad-Paulsen A; Donnadieu M; Noel M; Leger J; Simon D; Czernichow P
    J Endocrinol; 1994 Jun; 141(3):541-6. PubMed ID: 8071652
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Urinary GH secretion correlates with plasma GH levels during sleep and GHRH stimulation tests but not during the L-dopa stimulation test in prepubertal children.
    Porquet D; Fjellestad-Paulsen A; Leger J; Simon D; Czernichow P; Evain-Brion D
    Horm Res; 1993; 39(1-2):19-24. PubMed ID: 8406335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The interaction between clonidine and growth hormone releasing hormone in the stimulation of growth hormone secretion in man.
    Suri D; Hindmarsh PC; Brain CE; Pringle PJ; Brook CG
    Clin Endocrinol (Oxf); 1990 Sep; 33(3):399-406. PubMed ID: 2147600
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pituitary responsiveness to GH-releasing hormone, GH-releasing peptide-2 and thyrotrophin-releasing hormone in critical illness.
    Van den Berghe G; de Zegher F; Bowers CY; Wouters P; Muller P; Soetens F; Vlasselaers D; Schetz M; Verwaest C; Lauwers P; Bouillon R
    Clin Endocrinol (Oxf); 1996 Sep; 45(3):341-51. PubMed ID: 8949573
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nocturnal release of immunoreactive growth hormone-releasing hormone and growth hormone in normal children.
    Tapanainen P; Rantala H; Leppäluoto J; Lautala P; Käär ML; Knip M
    Pediatr Res; 1989 Nov; 26(5):404-9. PubMed ID: 2510118
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methionine potentiates both basal and GHRH-induced GH secretion in children.
    Bellone J; Farello G; Bartolotta E; Aimaretti G; Bellone S; Mucci M; De Matteis F; Ghigo E
    Clin Endocrinol (Oxf); 1997 Jul; 47(1):61-4. PubMed ID: 9302373
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of endogenous GHRH in arginine-, insulin-, clonidine- and l-dopa-induced GH release in normal subjects.
    Hanew K; Utsumi A
    Eur J Endocrinol; 2002 Feb; 146(2):197-202. PubMed ID: 11834428
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endogenous growth hormone (GH)-releasing hormone is required for GH responses to pharmacological stimuli.
    Jaffe CA; DeMott-Friberg R; Barkan AL
    J Clin Invest; 1996 Feb; 97(4):934-40. PubMed ID: 8613546
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preservation of dopaminergic and alpha-adrenergic function in children with growth hormone neurosecretory dysfunction.
    Bercu BB; Root AW; Shulman DI
    J Clin Endocrinol Metab; 1986 Oct; 63(4):968-73. PubMed ID: 3018032
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Growth hormone (GH) profiles with successive provocation by GH-releasing hormone and arginine in children: a clinical appraisal.
    Sato T; Igarashi N; Miyagawa K; Shimizu M; Nishikawa T
    Endocrinol Jpn; 1991 Feb; 38(1):33-8. PubMed ID: 1915111
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The sequential administration of growth hormone-releasing hormone followed 120 minutes later by hexarelin, as an effective test to assess the pituitary GH reserve in man.
    Micic D; Popovic V; Kendereski A; Peino R; Dieguez C; Casanueva FF
    Clin Endocrinol (Oxf); 1996 Nov; 45(5):543-51. PubMed ID: 8977750
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma growth hormone responses to growth hormone-releasing hormone in children of short stature.
    Tsai WY; Chen SH; Lee JS
    Taiwan Yi Xue Hui Za Zhi; 1989 Aug; 88(8):801-5. PubMed ID: 2512368
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Behavior of growth hormone after stimulation with growth hormone releasing hormone (GHRH) in children with disorders of the hypothalamo-hypophyseal axis and girls with Turner syndrome].
    Schmitt K; Schober E; Birnbacher R; Frisch H
    Klin Padiatr; 1996; 208(1):29-34. PubMed ID: 8851324
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of growth hormone-releasing effect of growth hormone-releasing hormone, clonidine and pyridostigmine in normal children and adolescents. GH-releasing effect of GHRH, clonidine and pyridostigmine.
    Ghigo E; Arvat E; Nicolosi M; Mazza E; Camanni F
    Panminerva Med; 1990; 32(1):1-3. PubMed ID: 2263395
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of pulsatile administration of growth hormone (GH)-releasing hormone on short term linear growth in children with GH deficiency.
    Gelato MC; Ross JL; Malozowski S; Pescovitz OH; Skerda M; Cassorla F; Loriaux DL; Merriam GR
    J Clin Endocrinol Metab; 1985 Sep; 61(3):444-50. PubMed ID: 3926806
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nocturnal continuous infusion of growth hormone (GH)-releasing hormone results in a dose-dependent accentuation of episodic GH secretion in normal men.
    Sassolas G; Garry J; Cohen R; Bastuji H; Vermeulen E; Cabrera P; Roussel B; Jouvet M
    J Clin Endocrinol Metab; 1986 Oct; 63(4):1016-22. PubMed ID: 3091627
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reliability of provocative tests to assess growth hormone secretory status. Study in 472 normally growing children.
    Ghigo E; Bellone J; Aimaretti G; Bellone S; Loche S; Cappa M; Bartolotta E; Dammacco F; Camanni F
    J Clin Endocrinol Metab; 1996 Sep; 81(9):3323-7. PubMed ID: 8784091
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of hypothalamic-pituitary function in a combination of tests with four hypothalamic releasing hormones and L-dopa in normal subjects and in patients with hypothalamic and/or pituitary disorders.
    Bando H; Yamasaki R; Saito S
    Endocrinol Jpn; 1989 Oct; 36(5):705-20. PubMed ID: 2559840
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.